The Company’s vision is to achieve significant business
In proprietary Rx products by 2010 with strong presence in developed markets. It also aspires to be amongst to Top 5 Homoeopathic Companies with 40 Cr. In sales by 2010.
To translate these objectives into reality and to optimize value creation. The company has adopted a multipronged strategy. Entering high potential new markets with value added product offering and activity seeking overseas acquisition opportunities will be major thrust areas for P.H.L. in the coming years.

Together with the commitment of a multicultural workforce, P.H.L. continues to aggressively pursue its mission to become a Research based International Homoeopathic Company.